Psychiatry and Neurology, Neurology · Los Alamitos, CA
NPI
1184678583
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3791 Katella Ave, Suite 106
Los Alamitos, CA, 90720
Phone (562) 430-3114
Groups this clinician bills Medicare through
Medicare paid, 2024
$293K
8,516 services
Medicare patients, 2024
867
Average age 76
Drug cost, 2024
$907K
3,241 prescriptions
Company payments, 2025
$3,489
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omid Omidvar was code 99233 (hospital e&m - subsequent), 868 times for 344 patients. In total Omid Omidvar billed 8,516 services in 38 codes, and Medicare paid $293K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 868 | 344 | $97.41 | $85K |
| 99214 Office E&M - Established | Office | 448 | 255 | $102.20 | $46K |
| 99232 Hospital E&M - Subsequent | Facility | 387 | 206 | $65.18 | $25K |
| 99223 Hospital E&M - Initial | Facility | 254 | 247 | $136.30 | $35K |
| 99215 Office E&M - Established | Office | 193 | 130 | $141.13 | $27K |
| 95816 Neurologic | Facility | 112 | 109 | $47.18 | $5,284 |
| 99291 Critical Care E&M | Facility | 86 | 84 | $173.54 | $15K |
| 99222 Hospital E&M - Initial | Facility | 80 | 79 | $106.29 | $8,503 |
| 99204 Office E&M - New | Office | 25 | 25 | $124.67 | $3,117 |
| 99443 Telephone Services | Office | 22 | 13 | $106.14 | $2,335 |
| 96132 Behavioral Health Services | Office | 13 | 13 | $110.44 | $1,436 |
| 95819 Neurologic | Facility | 13 | 13 | $47.70 | $620 |
| 96138 Behavioral Health Services | Office | 13 | 13 | $32.50 | $423 |
| 96139 Behavioral Health Services | Office | 13 | 13 | $33.45 | $435 |
By year: 2022 $269K for 7,863 services; 2023 $313K for 8,513 services; 2024 $293K for 8,516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Omid Omidvar prescribed most often to Medicare patients was Memantine Hcl, with 223 prescriptions and refills. In total Omid Omidvar wrote 3,241 Medicare prescriptions that cost $907K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 223 | 442 | 64 | $5,849 |
| Gabapentin Generic | 203 | 323 | 50 | $2,593 |
| Donepezil Hcl Generic | 182 | 395 | 50 | $2,061 |
| Rasagiline Mesylate Generic | 104 | 210 | 30 | $21K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 102 | 204 | 32 | $8,130 |
| Candesartan Cilexetil Generic | 100 | 228 | 30 | $6,064 |
| Mirtazapine Generic | 87 | 176 | 22 | $1,026 |
| Citalopram Hbr Citalopram Hydrobromide | 81 | 184 | 21 | $392 |
| Levetiracetam Generic | 77 | 183 | 23 | $3,556 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 74 | 190 | 27 | $2,614 |
| Galantamine Er Galantamine Hbr | 66 | 110 | 21 | $4,356 |
| Rivastigmine Generic | 62 | 114 | 28 | $17K |
| Duloxetine Hcl Generic | 61 | 135 | 18 | $2,279 |
| Amantadine Amantadine Hcl | 55 | 99 | 14 | $2,413 |
| Primidone Generic | 54 | 79 | Under 11 | $2,205 |
Brand drugs: - claims; generic drugs: 2,718 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omid Omidvar $3,489 ($3,489 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novartis Pharmaceuticals Corporation with $497.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 25 | $497 |
| Abbvie Inc. ABBV | 19 | $372 |
| MDD US Operations, LLC | 13 | $321 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $240 |
| Boston Scientific Corporation BSX | 3 | $237 |
| Eisai Inc. 4523.T | 6 | $161 |
| Argenx US, Inc. ARGX | 8 | $157 |
| Amgen Inc. AMGN | 5 | $145 |
| Merz Pharmaceuticals, LLC | 4 | $133 |
| Lundbeck LLC | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.